These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 10938026

  • 1. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U.
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [Abstract] [Full Text] [Related]

  • 2. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, Hallmans G.
    Circulation; 1998 Nov 24; 98(21):2241-7. PubMed ID: 9826309
    [Abstract] [Full Text] [Related]

  • 3. The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project.
    Nordenhem A, Leander K, Hallqvist J, de Faire U, Sten-Linder M, Wiman B.
    Thromb Res; 2005 Nov 24; 116(3):223-32. PubMed ID: 15935831
    [Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB.
    Stroke; 1996 Jun 24; 27(6):1066-71. PubMed ID: 8650716
    [Abstract] [Full Text] [Related]

  • 5. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
    Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G.
    Stroke; 2000 Jan 24; 31(1):26-32. PubMed ID: 10625711
    [Abstract] [Full Text] [Related]

  • 6. Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction.
    Eriksson-Berg M, Egberg N, Eksborg S, Schenck-Gustafsson K.
    Thromb Res; 2002 Mar 15; 105(6):481-6. PubMed ID: 12091046
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictive value of fibrinolytic factors in coronary heart disease.
    Wiman B.
    Scand J Clin Lab Invest Suppl; 1999 Mar 15; 230():23-31. PubMed ID: 10389198
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
    Akanji AO, Abdullah A, Tahzeeb S.
    Eur J Clin Invest; 1997 May 15; 27(5):380-6. PubMed ID: 9179544
    [Abstract] [Full Text] [Related]

  • 19. Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.
    Wållberg-Jonsson S, Dahlén GH, Nilsson TK, Rånby M, Rantapää-Dahlqvist S.
    Clin Rheumatol; 1993 Sep 15; 12(3):318-24. PubMed ID: 8258230
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.